Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Female Breast Cancer Patients × fluzoparib × Breast × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Her-2 Negative Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Female Breast Cancer Patients 1 Breast Cancer Metastatic 1 Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06254066 2024-02-12

Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer

Zhejiang Cancer Hospital

Phase 2 Not yet recruiting

Female Breast Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡